Michelle Rico - Proto Script CEO
| PSCR Stock | USD 0.0001 0.00 0.00% |
CEO
Ms. Michelle Rico is President, Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary, Director of the Company. She was the Chief Executive Officer of ProtoScript Pharmaceuticals, Corporationration since 2011. She is a veteran of the medical industry, she has built a large nationwide network of clients. She has work experience with insurance companies, clinics, doctors offices, hospitals, pharmacies, and home medical equipment companies. She has experience in compliance, provider relations, case management, billing, marketing and sales in the HME industry. As an experienced leader, her expertise encompasses setting up and licensing DME and medical business billing and billing software, management, logistics, policies and procedures, cost analysis, sales and marketing, finance and information technology. From start to finish, she brings a wealth of knowledge to all areas of HME. Her 20 plus years in the industry have given her extensive knowledge of the insurance industry and MedicareMedicaid. since 2016.
| Age | 55 |
| Tenure | 9 years |
| Phone | 855-476-7679 |
| Web | https://www.psphomecare.com |
Proto Script Management Efficiency
The company has return on total asset (ROA) of (2.4096) % which means that it has lost $2.4096 on every $100 spent on assets. This is way below average. Proto Script's management efficiency ratios could be used to measure how well Proto Script manages its routine affairs as well as how well it operates its assets and liabilities.Management Performance
| Return On Asset | -2.41 |
Proto Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Proto Script a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -2.41 | |||
| Operating Margin | (1.60) % | |||
| Current Valuation | 464.66 K | |||
| Shares Outstanding | 49.14 M | |||
| Shares Owned By Insiders | 10.18 % | |||
| Price To Earning | 17.07 X | |||
| Price To Sales | 0.15 X | |||
| Revenue | 788.96 K | |||
| Gross Profit | 564.47 K | |||
| EBITDA | (962.57 K) |
Pair Trading with Proto Script
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Proto Script position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Proto Script will appreciate offsetting losses from the drop in the long position's value.Moving against Proto Pink Sheet
| 0.84 | RBA | RB Global | PairCorr |
| 0.63 | CTAS | Cintas | PairCorr |
| 0.49 | GPN | Global Payments | PairCorr |
| 0.45 | RKLIF | Rentokil Initial plc | PairCorr |
| 0.4 | TLPFF | Teleperformance SE | PairCorr |
The ability to find closely correlated positions to Proto Script could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Proto Script when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Proto Script - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Proto Script Pharmaceutical to buy it.
The correlation of Proto Script is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Proto Script moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Proto Script Pharmac moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Proto Script can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Proto Pink Sheet Analysis
When running Proto Script's price analysis, check to measure Proto Script's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Proto Script is operating at the current time. Most of Proto Script's value examination focuses on studying past and present price action to predict the probability of Proto Script's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Proto Script's price. Additionally, you may evaluate how the addition of Proto Script to your portfolios can decrease your overall portfolio volatility.